Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Change in Cash: 2024-2025

Historic Change in Cash for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $13.3 million.

  • Kura Oncology's Change in Cash rose 210.43% to $13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.8 million, marking a year-over-year change of. This contributed to the annual value of $187.1 million for FY2024, which is 1392.07% up from last year.
  • Kura Oncology's Change in Cash amounted to $13.3 million in Q3 2025, which was down 56.52% from $30.7 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Change in Cash ranged from a high of $175.0 million in Q4 2024 and a low of -$173.2 million during Q1 2025.
  • Its 2-year average for Change in Cash is $8.3 million, with a median of $4.3 million in 2024.
  • Within the past 5 years, the most significant YoY rise in Kura Oncology's Change in Cash was 734.35% (2025), while the steepest drop was 4,235.46% (2025).
  • Over the past 2 years, Kura Oncology's Change in Cash (Quarterly) stood at $175.0 million in 2024, then skyrocketed by 210.43% to $13.3 million in 2025.
  • Its Change in Cash was $13.3 million in Q3 2025, compared to $30.7 million in Q2 2025 and -$173.2 million in Q1 2025.